Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and effectiveness of Oxyresveratrol hair tonic in healthy volunteers and patients with androgenetic alopecia
TCTR20240618001Phase 1Recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of oxyresveratrol in androgenetic alopecia (AGA), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoints: Safety of oxyresveratrol hair tonic and Effectiveness of oxyresveratrol hair tonic. Started May 2025; status: recruiting.
02
Drugs
oxyresveratrol
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on TCTR20240618001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240618001.